There are still many other studies showing the influence of various factors on the inhibition of the NLRP3 inflammasome in COPD, i.e. lipoxin receptor agonist BML-111 (44) or (–)-Epicatechin – a type of flavonoid (45). The gene discussed is NLRP3; the disease is chronic obstructive pulmonary disease.